Global Thyroid Eye Disease (TED) Treatment Market Research Report 2023-2029: Strategic Recommendations Include Minimally Invasive Surgical Techniques and Expansion into Iron Deficient Regions

DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "Global Thyroid Eye Disease (TED) Treatment Market (2023 Edition): Analysis By Therapeutic Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)" report has been added to  ResearchAndMarkets.com's offering.

During the forecast period, 2024-2029, the Global Thyroid Eye Disease Treatment market is expected to grow at a CAGR of 13.24%. The Global Thyroid Eye Disease Treatment Market is expected to generate USD 8.24 Billion by the end of 2029, up from USD 3.46 Billion in 2022. .

The research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also analyzes growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. .

The market for treatments of thyroid eye disease (TED) is witnessing substantial expansion as a result of the increasing prevalence of this ailment. Graves' disease, a prevalent autoimmune illness that affects the thyroid gland, is frequently linked to TED (thyroid eye disease). The prevalence of autoimmune disorders, such as Graves' disease, is on the rise, leading to a corresponding increase in the number of cases of thyroid eye disease (TED). The expansion of the patient population contributes to the increasing demand for TED treatments. .

The introduction of biologic pharmaceuticals and targeted therapies is altering the landscape of TED treatment. In clinical trials, monoclonal antibodies that target specific immune response molecules, such as the IL-6 receptor and IGF-1 receptor, have demonstrated potential. These biologics can assist in modulating the immune response, reducing inflammation, and relieving TED symptoms. The development of these specialized treatments offers patients with mild to severe TED new treatment options.

Scope of the Report

• The report analyses the Thyroid Eye Disease Treatment Market by Value (USD Million).
• The report presents the analysis of Thyroid Eye Disease Treatment Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Thyroid Eye Disease Treatment Market by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins).
• The report analyses the Thyroid Eye Disease Treatment Market By Route of Administration (Oral, Parenteral, Topical)
• The report analyses the Thyroid Eye Disease Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Therapeutic Type, By Route of Administration & By Distribution Channels.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. 

Strategic Recommendations

• Minimally Invasive Surgical Techniques
• Expansion into Iron Deficient Regions

Competitive Positioning

• Companies' Product Positioning
• Market Position Matrix
• Market Share Analysis of Thyroid Eye Disease Treatment Market

Company Profiles

• Horizon Therapeutics
• GSK plc
• Santen Pharmaceuticals
• Viridian Therapeutics
• Bioxcel Therapeutics
• Novartis AG
• Roche Holding AG
• Sanofi
• Teva Pharmaceuticals
• Abbvie Inc

For more information about this report visit https://www.researchandmarkets.com/r/igf2j3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo:https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets